Moreover, the PIM serine/threonine kinase aberrant expression and activation appeared in several cancerous contexts, including primary mediastinal large B-cell lymphoma and cHL, promoting cancer cell survival and immune surveillance escape partly via modulating JAK/STAT activity [52,53]. Here, SOAT1 is linked to cancer.